Trial record 1 of 4 for:    POINT: NEW ACUTE TIA
Previous Study | Return to List | Next Study

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by University of California, San Francisco
Sponsor:
Collaborators:
Neurological Emergencies Treatment Trials Network (NETT)
Medical University of South Carolina
The EMMES Corporation
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00991029
First received: October 6, 2009
Last updated: April 13, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)
No publications provided by University of California, San Francisco

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):